Stock MRNS MARINUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Marinus Pharmaceuticals, Inc.

Equities

MRNS

US56854Q2003

Real-time Estimate Cboe BZX
Other stock markets
 02:11:15 2024-05-06 pm EDT 		5-day change 1st Jan Change
1.545 USD +2.32% Intraday chart for Marinus Pharmaceuticals, Inc. +8.93% -85.97%
Apr. 17 Truist Adjusts Marinus Pharmaceuticals' PT to $10 From $25, Keeps Buy Rating MT
Apr. 16 Baird Downgrades Marinus Pharmaceuticals to Neutral, Price Target at $2 MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. MRNS Stock
  4. Revisions Marinus Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW